Evaluation of oxygen consumption of culture medium and in vitro photodynamic effect of talaporfin sodium in lung tumor cells

Photomedicine and Laser Surgery

Volumn 28, Issue 3, 2010, Pages 385-390

  Tomioka, Yutaka ^a   Kushibiki, Toshihiro ^a   Awazu, Kunio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BENZOIC ACID; CONTINUOUS WAVE; CULTURE MEDIUM; EFFECT OF OXYGEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT PROBES; HIGH DOSE; HYDROXYL RADICALS; IN-VITRO; LEWIS LUNG CARCINOMATA; LOW DOSE; LOW OXYGEN; LUNG TUMOR; MTT ASSAYS; NEOANGIOGENESIS; OXYGEN CONSUMPTION; OXYGEN MEASUREMENTS; OXYGEN MICROELECTRODES; PHOTODYNAMIC EFFECT; RADICAL IONS; REACTIVE OXYGEN SPECIES; SINGLET OXYGEN; SINGLET OXYGEN PRODUCTION; TARGET CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

BIOLOGICAL ORGANS; CELL CULTURE; CLARIFICATION; FLUORESCENCE; LASERS; OXYGEN; PHOTOSENSITIZERS; PROBES; SEMICONDUCTOR GROWTH; SEMICONDUCTOR LASERS;

PHOTODYNAMIC THERAPY;

PHOTOSENSITIZING AGENT; PORPHYRIN; REACTIVE OXYGEN METABOLITE; TALAPORFIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; BLEACHING; CULTURE MEDIUM; DRUG EFFECT; LEWIS CARCINOMA; LUNG TUMOR; METABOLISM; MOUSE; MOUSE STRAIN; NEOVASCULARIZATION (PATHOLOGY); OXYGEN CONSUMPTION; PHOTOCHEMOTHERAPY; TUMOR CELL CULTURE;

ANIMALS; CARCINOMA, LEWIS LUNG; CULTURE MEDIA; LUNG NEOPLASMS; MICE; MICE, INBRED STRAINS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN CONSUMPTION; PHOTOBLEACHING; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953944812     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2008.2468     Document Type: Article

References (40)

1. Schuitmaker, J.J., Baas, P., Van Leengoed, H.L., Van der Meulen, F.W., Star, W.M., and Van Zandwijk, N. (1996). Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol. B 34, 3-12.
2. Lightdale, C.J., Heier, S.K., Marcon, N.E., et al. (1995). Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest. Endosc. 42, 507-512.
3. Verma, S., Watt, G.M., Mai, Z., and Hasan, T. (2007). Strategies for enhanced photodynamic therapy effects. Photochem. Photobiol. 83, 996-1005.
4. Buytaert, E., Dewaele, M., and Agostinis, P. (2007). Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta 1776, 86-107.
5. Foote, C.S. (1991). Definition of type I and type II photosensitized oxidation. Photochem. Photobiol. 54, 659.
6. Moor, A.C., Lagerberg, J. W., Tijssen, K., et al. (1997). In vitro fluence rate effects in photodynamic reactions with AIPcS4 as sensitizer. Photochem. Photobiol. 66, 860-865.
7. Georgakoudi, I., Nichols, M.G., and Foster, T.H. (1997). The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem. Photobiol. 65, 135-144.
8. Georgakoudi, I., and Foster, T.H. (1998). Singlet oxygenversus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry. Photochem. Photobiol. 67, 612-625.
9. Iinuma, S., Schomacker, K.T., Wagnieres, G., et al. (1999). In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res. 59, 6164-6170.
10. Edrei, R., and Kimel, S. (1999). Oxygen depletion during in vitro photodynamic therapy: structure-activity relationships of sulfonated aluminum phthalocyanines. J. Photochem. Photobiol. B: Biol. 50, 197-203.
11. Finlay, J.C., Mitra, S., and Foster, T.H. (2002). In vivo mTHPC photobleaching in normal rat skin exhibits unique irradiance-dependent features. Photochem. Photobiol. 75, 282-288.
12. Dysart, J.S., Patterson, M.S., Farrell, T.J., and Singh, G. (2002). Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells. Photochem. Photobiol. 75, 289-295.
13. Foster, T.H., Hartley, D.F., Nichols, M.G., and Hilf, R. (1993). Fluence rate effects in photodynamic therapy of multicell tumor spheroids. Cancer Res. 53, 1249-1254.
14. Henning, J.P., Foumier, R.L., and Hampton, J.A. (1995). A transient mathematical model of oxygen depletion during photodynamic therapy. Radiat. Res. 142, 221-226.
15. Ochsner, M. (1997). Photophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol. B: Biol. 39, 1-18.
16. Sitnik, T.M., Hampton, J.A., and Henderson, B.W. (1998). Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br. J. Cancer 77, 1386-1394.
17. Henderson, B.W., Busch, T.M., Vaughan, L.A., et al. (2000). Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res. 60, 525-529.
18. Chen, Q., Huang, Z., Chen, H., Shapiro, H., Beckers, J., and Hetzel, F.W. (2002). Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem. Photobiol. 76, 197-203.
19. Engbrecht, B.W., Menon, C., Kachur, A.V., Hahn, S.M., and Fraker, D.L. (1999). Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Cancer Res. 59, 4334-4342.
20. Fingar, V.H., Kik, P.K., Haydon, P.S., et al. (1999). Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br. J. Cancer 79, 1702-1708.
21. Semenza, G.L. (2001). HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13, 167-171.
22. Forsythe, J.A., Jiang, B.H., Iyer, N.V., et al. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16, 4604-4613.
23. Deininger, M.H., Weinschenk, T., Morgalla, M.H., Meyermann, R., and Schluesener, H.J. (2002). Release of regulators of angiogenesis following hypocrellin-A and -B photodynamic therapy of human brain tumor cells. Biochem. Biophys. Res. Commun. 298, 520-530.
24. Ferrario, A., Von Tiehl, K.F., Rucker, N., Schwarz, M.A., Gill, P.S., and Gomer, C.J. (2000). Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 60, 4066-4069.
25. Jiang, F., Zhang, Z.G., Katakowski, M., et al. (2004). Angiogenesis induced by photodynamic therapy in normal rat brains. Photochem. Photobiol. 79, 494-498.
26. Schmidt-Erfurth, U., Schlotzer-Schrehard, U., Cursiefen, C., Michels, S., Beckendorf, A., and Naumann, G.O. (2003). Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 44, 4473-4480.
27. Ferrario, A., Von Tiehl, K., Wong, S., Luna, M., and Gomer, C.J. (2002). Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res. 62, 3956-3961.
28. Chen, B., Pogue, B.W., Zhou, X., et al. (2005). Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model. Clin. Cancer Res. 11, 720-727.
29. Killion, J.J., Radinsky, R., and Fidler, I.J. (1998-1999). Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev. 17, 279-284.
30. Setsukinai, K., Urano, Y., Kakinuma, K., Majima, H.J., and Nagano, T. (2003). Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J. Biol. Chem. 278, 3170-3175.
31. Kushibiki, T., Sakai, M., and Awazu, K. (2008). Differential effects of photodynamic therapy on morphologically distinct tumor cells derived from a single precursor cell. Cancer Lett. 268, 244-251.
32. Foster, T.H., Murant, R.S., Bryant, R.G., Knox, R.S., Gibson, S.L., and Hilf, R. (1991). Oxygen consumption and diffusion effects in photodynamic therapy. Radiation Res. 126, 296-303.
33. Gibson, S.L., Foster, T.H., Feins, R.H., Raubertas, R.F., Fallon, M.A., and Hilf, R. (1994). Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br. J. Cancer 69, 473-481.
34. Dougherty, T.J., Lawrence, G., Kaufman, J.H., Boyle, D., Weishaupt, K.R., and Goldfarb, A. (1979). Photoradiation in the treatment of recurrent breast carcinoma. J. Natl. Cancer Inst. 62, 231-237.
35. Moan, J., Pettersen, E.O., and Christensen, T. (1979). The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. Br. J. Cancer 39, 398-407.
36. Peng, Q., Moan, J., and Nesland, J.M. (1996). Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct. Pathol. 20, 109-129.
37. Peng, Q., and Nesland, J.M. (2004). Effects of photodynamic therapy on tumor stroma. Ultrastruct. Pathol. 28, 333-340.
38. Brahimi-Horn, M.C., and Pouyssegur, J. (2005). The hypoxiainducible factor and tumor progression along angiogenic pathway. Int. Rev. Cytol. 242, 157-213.
39. Carmeliet, P., Dor, Y., Herbert, J.M., et al. (1998). Role of HIF-1a in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 394, 485-490.
40. Semenza, G.L., Roth, P.H., Fang, H.M., and Wang, G.L. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor-1, J. Biol. Chem. 269, 23757-23763.